Search Results

There are 49899 results for: content related to: Small reduction in quality of life seen with bevacizumab maintenance in patients with ovarian cancer

  1. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases

    British Journal of Surgery

    Volume 98, Issue 3, March 2011, Pages: 399–407, D. A. Wicherts, R. J. de Haas, M. Sebagh, E. Saenz Corrales, D. L. Gorden, F. Lévi, B. Paule, D. Azoulay, D. Castaing and R. Adam

    Version of Record online : 15 DEC 2010, DOI: 10.1002/bjs.7368

  2. You have free access to this content
    Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  3. You have free access to this content
    Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas

    Cancer

    Volume 116, Issue 17, 1 September 2010, Pages: 3988–3999, Marc C. Chamberlain

    Version of Record online : 19 AUG 2010, DOI: 10.1002/cncr.25256

  4. You have free access to this content
    Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: e304–e310, Yu Xu, Qi Zhang, Xiaoli Kang, Ying Zhu, Jiakai Li, Yiye Chen and Peiquan Zhao

    Version of Record online : 7 MAY 2013, DOI: 10.1111/aos.12055

  5. Anti-angiogenic therapies for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea ADW Wagner, Dirk Arnold, Axel AG Grothey, Johannes Haerting and Susanne Unverzagt

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD005392.pub3

  6. You have free access to this content
    Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies

    Cancer

    Volume 121, Issue 7, April 1, 2015, Pages: 997–1007, Kathryn M. Field, Justin T. Jordan, Patrick Y. Wen, Mark A. Rosenthal and David A. Reardon

    Version of Record online : 26 SEP 2014, DOI: 10.1002/cncr.28935

  7. Angiogenesis inhibitors for the treatment of ovarian cancer

    Intervention Review

    The Cochrane Library

    Kezia Gaitskell, Igor Martinek, Andrew Bryant, Sean Kehoe, Shibani Nicum and Jo Morrison

    Published Online : 7 SEP 2011, DOI: 10.1002/14651858.CD007930.pub2

  8. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  9. You have free access to this content
    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L Subramanian and Gianni Virgili

    Published Online : 15 SEP 2014, DOI: 10.1002/14651858.CD011230.pub2

  10. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea Wagner, Christoph Thomssen, Johannes Haerting and Susanne Unverzagt

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD008941.pub2

  11. Antiangiogenic Therapy for Cancer: An Update

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 12, December 2012, Pages: 1095–1111, Belal Al-Husein, Maha Abdalla, Morgan Trepte, David L. DeRemer and Payaningal R. Somanath

    Version of Record online : 3 DEC 2012, DOI: 10.1002/phar.1147

  12. Weighing up the benefits and harms of a new anti-cancer drug: a survey of Australian oncologists

    Internal Medicine Journal

    Volume 45, Issue 8, August 2015, Pages: 834–842, L. Chim, G. Salkeld, M. R. Stockler and L. Mileshkin

    Version of Record online : 28 JUL 2015, DOI: 10.1111/imj.12802

  13. You have free access to this content
    Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma

    Cancer

    Volume 119, Issue 2, 15 January 2013, Pages: 339–347, Darrell White, Adetola Kassim, Birbal Bhaskar, Jing Yi, Karen Wamstad and Virginia E. Paton

    Version of Record online : 18 JUL 2012, DOI: 10.1002/cncr.27745

  14. You have free access to this content
    Antiangiogenic therapy for high-grade glioma

    Intervention Review

    The Cochrane Library

    Mustafa Khasraw, Malaka S Ameratunga, Robin Grant, Helen Wheeler and Nick Pavlakis

    Published Online : 22 SEP 2014, DOI: 10.1002/14651858.CD008218.pub3

  15. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 726–734, Axel Grothey, E. Dawn Flick, Allen L. Cohn, Tanios S. Bekaii-Saab, Johanna C. Bendell, Mark Kozloff, Nancy Roach, Yong Mun, Susan Fish and Herbert I. Hurwitz

    Version of Record online : 16 MAY 2014, DOI: 10.1002/pds.3633

  16. You have free access to this content
    Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft

    International Journal of Cancer

    Volume 136, Issue 7, 1 April 2015, Pages: 1718–1730, Gewen Tan, Hideki Kasuya, Tevfik Tolga Sahin, Kazuo Yamamura, Zhiwen Wu, Yusuke Koide, Yoshihiro Hotta, Toshio Shikano, Suguru Yamada, Akiyuki Kanzaki, Tsutomu Fujii, Hiroyuki Sugimoto, Shuji Nomoto, Yoko Nishikawa, Maki Tanaka, Naoko Tsurumaru, Toshie Kuwahara, Saori Fukuda, Toru Ichinose, Toyone Kikumori, Shin Takeda, Akimasa Nakao and Yasuhiro Kodera

    Version of Record online : 26 SEP 2014, DOI: 10.1002/ijc.29163

  17. You have free access to this content
    Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial

    BJU International

    Volume 107, Issue 2, January 2011, Pages: 214–219, Sergio Bracarda, Joaquim Bellmunt, Bohuslav Melichar, Sylvie Négrier, Emilio Bajetta, Alain Ravaud, Vesna Sneller and Bernard Escudier

    Version of Record online : 13 OCT 2010, DOI: 10.1111/j.1464-410X.2010.09707.x

  18. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Gianni Virgili, Mariacristina Parravano, Jennifer R Evans, Iris Gordon and Ersilia Lucenteforte

    Published Online : 22 JUN 2017, DOI: 10.1002/14651858.CD007419.pub5

  19. Bevacizumab (Avastin)

    Handbook of Therapeutic Antibodies

    Eduardo Díaz-Rubio, Edith A. Perez, Guiseppe Giaccone, Pages: 779–812, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch29

  20. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases

    Journal of Surgical Oncology

    Volume 106, Issue 7, 1 December 2012, Pages: 892–897, Anne E.M. van der Pool, Hendrick A. Marsman, Joanne Verheij, Fibo J. Ten Kate, Alexander M.M. Eggermont, Jan N.M. IJzermans and Cornelis Verhoef

    Version of Record online : 2 MAY 2012, DOI: 10.1002/jso.23142